These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26057693)

  • 1. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.
    Xu C; Fang D; Chen X; Xinyue L; Nie Y; Xie Y; Ma Y; Deng S; Zhang Z; Song X
    Eur J Pharmacol; 2015 Sep; 762():364-71. PubMed ID: 26057693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice.
    Fujisaka S; Usui I; Kanatani Y; Ikutani M; Takasaki I; Tsuneyama K; Tabuchi Y; Bukhari A; Yamazaki Y; Suzuki H; Senda S; Aminuddin A; Nagai Y; Takatsu K; Kobayashi M; Tobe K
    Endocrinology; 2011 May; 152(5):1789-99. PubMed ID: 21427223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan.
    Penna-de-Carvalho A; Graus-Nunes F; Rabelo-Andrade J; Mandarim-de-Lacerda CA; Souza-Mello V
    Exp Physiol; 2014 Dec; 99(12):1663-78. PubMed ID: 25326526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    Zhang Z; Li Z; Cao K; Fang D; Wang F; Bi G; Yang J; He Y; Wu J; Wei Y; Song X
    J Hypertens; 2017 Jul; 35(7):1442-1456. PubMed ID: 28244896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet.
    Souza-Mello V; Gregório BM; Cardoso-de-Lemos FS; de Carvalho L; Aguila MB; Mandarim-de-Lacerda CA
    Clin Sci (Lond); 2010 Jun; 119(6):239-50. PubMed ID: 20415664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
    Aubert G; Burnier M; Dulloo A; Perregaux C; Mazzolai L; Pralong F; Zanchi A
    Metabolism; 2010 Jan; 59(1):25-32. PubMed ID: 19793594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.
    Sugimoto K; Qi NR; Kazdová L; Pravenec M; Ogihara T; Kurtz TW
    Hypertension; 2006 May; 47(5):1003-9. PubMed ID: 16567593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells.
    Yin SN; Liu M; Jing DQ; Mu YM; Lu JM; Pan CY
    Endocr Res; 2014; 39(2):66-72. PubMed ID: 24067162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice.
    Araki K; Masaki T; Katsuragi I; Tanaka K; Kakuma T; Yoshimatsu H
    Hypertension; 2006 Jul; 48(1):51-7. PubMed ID: 16717145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial direct adipotropic actions of pitavastatin in vitro and their manifestations in obese mice.
    Ishihara Y; Ohmori K; Mizukawa M; Hasan AU; Noma T; Kohno M
    Atherosclerosis; 2010 Sep; 212(1):131-8. PubMed ID: 20466374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
    Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
    Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways.
    He H; Yang D; Ma L; Luo Z; Ma S; Feng X; Cao T; Yan Z; Liu D; Tepel M; Zhu Z
    Hypertension; 2010 Apr; 55(4):869-79. PubMed ID: 20176998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
    Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blocker telmisartan prevents new-onset diabetes in pre-diabetes OLETF rats on a high-fat diet: evidence of anti-diabetes action.
    Zhao ZQ; Luo R; Li LY; Tian FS; Zheng XL; Xiong HL; Sun LT
    Can J Diabetes; 2013 Jun; 37(3):156-68. PubMed ID: 24070838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adipose tissue-independent insulin-sensitizing action of telmisartan: a study in lipodystrophic mice.
    Rong X; Li Y; Ebihara K; Zhao M; Aini W; Kusakabe T; Hirata M; Miyamoto L; Murray M; Nakao K
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1096-103. PubMed ID: 19770292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor γ among clinically used angiotensin II receptor blockers: drug-target interaction analyses.
    Kakuta H; Kurosaki E; Niimi T; Gato K; Kawasaki Y; Suwa A; Honbou K; Yamaguchi T; Okumura H; Sanagi M; Tomura Y; Orita M; Yonemoto T; Masuzaki H
    J Pharmacol Exp Ther; 2014 Apr; 349(1):10-20. PubMed ID: 24424487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients.
    Chujo D; Yagi K; Asano A; Muramoto H; Sakai S; Ohnishi A; Shintaku-Kubota M; Mabuchi H; Yamagishi M; Kobayashi J
    Hypertens Res; 2007 Dec; 30(12):1205-10. PubMed ID: 18344626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
    Clemenz M; Frost N; Schupp M; Caron S; Foryst-Ludwig A; Böhm C; Hartge M; Gust R; Staels B; Unger T; Kintscher U
    Diabetes; 2008 May; 57(5):1405-13. PubMed ID: 18184928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
    Tsukuda K; Mogi M; Iwanami J; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
    Hypertension; 2009 Oct; 54(4):782-7. PubMed ID: 19635982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.